Partnering & innovation

Novo Nordisk Compound Sharing

Driving innovation through sharing

Accelerate innovation

To accelerate innovation, we openly share novel peptide and protein analogues as well as antibodies for preclinical research.

Through this open innovation initiative, we offer easy and free access to selected high-quality and well-characterized compounds to curious and passionate scientists from around the world. We hope that sharing can advance the research of those who want to discover new mode of action and expand disease biology understanding, which can ultimately contribute to accelerating future breakthroughs for medical solutions.

The process and criteria are simple and transparent - we provide the compounds for free for you to validate your scientific hypothesis, you own the results and are encouraged to publish these. There is no reporting required but if you obtain exciting new results, you are welcome to get in touch for a discussion of the data and the possibilities for a future collaboration.

For COVID-19 related compounds, please contact Department Manager Theresa Bak-Thomsen, TBT@novonordisk.com.

The process

Through a few easy steps you can get access to our compounds

Available compounds

Explore and learn more about our compounds

Long-acting a-MSH analogue

NNC0070-0453

Long-acting amylin analogue

NNC0174-0839

Long-acting CCK analogue

NNC0368-0056

Long-acting GLP-1 analogue #1

NNC0090-1170

Long-acting GLP-1 analogue #2

NNC0113-0217

Long-acting GLP-2 analogue

NNC0103-0147

Long-acting glucagon analogue

NNC9204-0043

Partial glucagonR agonist

NNC9204-1702

Small molecule glucagonR antagonist

NNC0025-0926

Long-acting insulin analogue

NNC0100-0454

Liver-preferential insulin analogue

NNC0123-0327

InsR peptide antagonist (S961)

NNC0069-0961

PYY analogue - Y2 selective

NNC0165-1273

Long-acting PYY analogue

Coming soon

Anti-InsR mAb G6

NNC0276-3000

Anti-GLP-1R antibodies

mAb clone 7F38 and 3F52

Anti-IGF1R mAb 226

NNC0124-0226
Tine Glendorf and Lars Linderoth, scientists from the Novo Nordisk Compound Sharing team

Tine Glendorf and Lars Linderoth, scientists from the Novo Nordisk Compound Sharing team

Contact us

If you have questions or comments in relation to Compound Sharing do not hesitate to contact us. You are also welcome to take a look at the FAQs at the bottom of this page.

You can reach us at compoundsharing@novonordisk.com – we are looking forward to answering your questions.

Stay updated

Stay updated

Be the first to know when we add new compounds to the site or stories related to how our compounds are being used in the scientific community

E-mail address

Email is required Invalid email address

{{subscribeMessage}}

{{subscribeErrorMessage}}

FAQs

People often ask us

Group of colleagues inside a lab talking

Careers in R&D

We are looking for scientific talent to join us. If you are interested in joining our research and development teams, explore your opportunities at our careers page.

Partnering and open innovation

Partnering opportunities

Interested in partnering with Novo Nordisk? We constantly seek innovative alliances with academic and healthcare institutions, as well as leading biotechnology and pharmaceutical companies.